Mutation introduces a stop codon at position 924 upstream from the bZIP domain.
Amino acid replacement: ??term.
C5308137T
Q203term | vri-PA; Q84term | vri-PC; Q203term | vri-PD; Q84term | vri-PE; Q203term | vri-PF
Q202term
15% of stage 11-13 vri2/vrik05901 embryos show tracheal defects. During stages 14-17, 80% of vri2/vrik05901 embryos show weak tracheal defects (the general architecture of the trachea is preserved, but breaking of branches occurs and elongation and branching are abnormal) and 12% show strong tracheal defects (the tracheal architecture is strongly affected with complete disorganization and formation of sacs).
54% of stage 11-13 vri2/vri5R7.2 embryos show tracheal defects. During stages 14-17, 76% of vri2/vri5R7.2 embryos show weak tracheal defects (the general architecture of the trachea is preserved, but breaking of branches occurs and elongation and branching are abnormal) and 12% show strong tracheal defects (the tracheal architecture is strongly affected with complete disorganization and formation of sacs).
Homozygous border cell clones show only subtle delays in migration.
Bristles in homozygous clones are thinner and reduced in size than normal or are missing. The average distance between stout bristles of the triple row is reduced compared to wild type in homozygous clones, which is characteristic of smaller cells.
Homozygous embryos are shortened and the dorsal epidermis often appears wrinkled and reduced (leading to a slight 'tail-up' phenotype) and trachea are interrupted. Less frequently the head skeleton is abnormal and ventral denticles are fused or missing. Hemizygotes die as larvae. vri2/vri3 transheterozygotes exhibit shortening of wing vein L5.